# Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer

Source: https://onco.cc/trials/nct06576115/  
OnCo record `nct06576115` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of nab-paclitaxel and gemcitabine in pancreatic cancer, run by Barbara Ann Karmanos Cancer Institute, now recruiting.

## Summary

Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer is a phase 2, interventional study registered as NCT06576115 by Barbara Ann Karmanos Cancer Institute, with a registry enrolment figure of 30 participants, started 2025-02-28 and due to reach its primary completion in 2027-07. Interventions recorded: Nab paclitaxel; Gemcitabine; TheraBionic P1. Conditions listed: Metastatic Pancreatic Adenocarcinoma. Primary outcome: 6 Month Progression-Free Survival Rate (PFS 6). Pancreatic eligibility wording from the registry: "* Patients must have histologically or cytologically proven advanced metastatic adenocarcinoma of the pancreas". Sites: United States. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT06576115
- Phase: 2
- Setting: Treatment of Patients With Metastatic Pancreatic Cancer With Gemcitabine and Nab-Paclitaxel and Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF)
- Sponsor: Barbara Ann Karmanos Cancer Institute
- Enrolled: 30

## Sources

- ClinicalTrials.gov NCT06576115: https://clinicaltrials.gov/study/NCT06576115

## Connected records

- cancers: [Metastatic pancreatic ductal adenocarcinoma](https://onco.cc/cancers/metastatic-pdac/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/)
- drugs: [Gemcitabine](https://onco.cc/drugs/gemcitabine/), [Nab-paclitaxel](https://onco.cc/drugs/nab-paclitaxel/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06576115.json